Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Coates

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|January 31, 1998
Radiotherapy and chemotherapy in high-risk breast cancerA Goldhirsch, A S Coates, M Colleoni, et al.
Australian and New Zealand Journal of Medicine|December 1, 1974
Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidentsU Youngchaiyud, A S Coates, S Whittingham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction?A Goldhirsch, A S Coates, M Castiglione-Gertsch, et al.
Medical and Pediatric Oncology|January 1, 1988
Chemotherapy of advanced head and neck cancer: updated results of a randomized trial of the order of administration of sequential methotrexate and 5-fluorouracilJ F Mackintosh, A S Coates, M H Tattersall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2020
International consensus on treatment of early breast cancer: radiotherapy issues A response to 'International expert consensus on radiotherapy of early breast cancer'A Goldhirsch, A S Coates, R D Gelber, et al.
British Journal of Cancer|May 5, 2001
Clinical relevance of single item quality of life indicators in cancer clinical trialsJ Bernhard, M Sullivan, C Hürny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA M Childs, A S Coates, K M Cox, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1979
The survival of patients with malignant melanoma receiving BCG with or without chemotherapyM D Green, I R MacKay, J C Buckley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Lancet (London, England)|September 12, 2000
Taxanes as adjuvant for breast cancerA Goldhirsch, P Francis, M Castiglione-Gertsch, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|January 31, 1998
Radiotherapy and chemotherapy in high-risk breast cancerA Goldhirsch, A S Coates, M Colleoni, et al.
Australian and New Zealand Journal of Medicine|December 1, 1974
Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidentsU Youngchaiyud, A S Coates, S Whittingham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction?A Goldhirsch, A S Coates, M Castiglione-Gertsch, et al.
Medical and Pediatric Oncology|January 1, 1988
Chemotherapy of advanced head and neck cancer: updated results of a randomized trial of the order of administration of sequential methotrexate and 5-fluorouracilJ F Mackintosh, A S Coates, M H Tattersall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2020
International consensus on treatment of early breast cancer: radiotherapy issues A response to 'International expert consensus on radiotherapy of early breast cancer'A Goldhirsch, A S Coates, R D Gelber, et al.
British Journal of Cancer|May 5, 2001
Clinical relevance of single item quality of life indicators in cancer clinical trialsJ Bernhard, M Sullivan, C Hürny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA M Childs, A S Coates, K M Cox, et al.
The Australian and New Zealand Journal of Surgery|June 1, 1979
The survival of patients with malignant melanoma receiving BCG with or without chemotherapyM D Green, I R MacKay, J C Buckley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Lancet (London, England)|September 12, 2000
Taxanes as adjuvant for breast cancerA Goldhirsch, P Francis, M Castiglione-Gertsch, et al.
Pageof 15